Ninlaro is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Ninlaro is used in adults to treat multiple myeloma (bone marrow cancer), in combination chemotherapy with lenalidomide and dexamethasone.
This combination is usually given after treatment with at least one other cancer medicine has failed.
Ninlaro should not be used to treat people who are receiving maintenance treatment, or who have been newly diagnosed with multiple myeloma, except if they are participants in a controlled clinical trial.
For more information email [email protected]
You must be logged in to post a review.